Clinical trial
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia…
NCT00044226 · Milkhaus Laboratory, Industry · Unknown status
Key facts
| NCT number | NCT00044226 |
|---|---|
| Title | A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH). |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia |
| Lead sponsor | Milkhaus Laboratory, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Hyperplasia |
| Intervention type | Drug |
| Interventions | ML-04A |
| Enrollment | 350 |
| Start date | Apr 1, 2002 |
| Completion | Oct 1, 2002 |
| First posted | Aug 23, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: